Solution Study: Transforming MES With a Platform Approach

Session

Transforming MES With a Platform Approach

Solution Study

Thursday, March 21

12:45 PM - 01:15 PM

Live in Everett

Less Details

There is a fundamental technological shift taking place in the MES market driven by evolving technologies and new digital concepts that challenge the status quo. By 2025, 60% of new MES solutions will be “composed” rather than implemented, with new composable platforms taking the lead in the market. This new approach to MES promises previously unheard-of reductions in the effort and cost associated with traditional MES. This means that deploying a MES solution can happen in a matter of weeks — led by the people who are closest to the process (i.e., citizen developers supported by AI). This is the promise of a frontline operations platform: a composable, cloud-native, flexible, and user-friendly solution that encompasses what a MES solution looks like in the Pharma 4.0 reality. This type of platform inherently supports the quality and compliance requirements that are critical for the pharmaceutical industry — offering seamless data integrity and the ability to adopt continuous validation. This presentation explores the key capabilities and importance of the new MES architecture, and challenges the standard MES’ ability to deliver on these new expectations. In this session, you will learn:

Why the market is shifting toward composability and human-centric solutions
What a redefined MES looks like in terms of architecture, edge connectivity, AI, and of course compliance
How to align IT and OT operations strategies with the new MES technologies, using a Pharma 4.0 perspective

Speaker

Gilad Langer

Industry Practice Lead, Tulip Interfaces, Inc.

Dr. Gilad Langer is an accomplished business leader with 28+ years of experience in digital transformation, manufacturing IT, engineering services delivery, and technical operations. He has deep domain expertise in Digital Technologies and Manufacturing Business Systems (IIoT, Big Data, AI, MES, MI, PLM, QMS, DCS, & SCADA). He has an accomplished track record of Digital Transformation to drive high levels of operational performance in manufacturing industries with a specific focus in the regulated Life Sciences industries (pharma, biotech, & med device). He has also served as trusted adviser and business consultant in the areas of technology directions, industry strategy, and software implementations. His focus and passion is next generation (Pharma 4.0) digital technologies and IIoT for manufacturing. Dr. Langer started his career in academia, researching concepts and architectures for agile manufacturing systems using novel concepts that were the archetype for Industry 4.0 and Industrial IoT. He takes a systematic and strategic approach that he has honed throughout his career in different roles including consulting, sales, marketing, product strategy, project management, software development and implementation, and research.

Join Gilad Langer
Book Now!

Company

Tulip Interfaces, Inc.

https://tulip.co

Tulip, the leader in frontline operations, is empowering the world’s leading companies to improve the productivity of their teams, the quality of their output, and the efficiency of their operations. Companies use Tulip to digitally transform their operations and gain real-time visibility into the people, machines and processes involved in production—all in a matter of days. Companies of all sizes, across industries including consumer electronics, pharmaceuticals, aerospace and defense, contract manufacturing, automotive, apparel, medical devices and more, have implemented Tulip’s intuitive software and hardware platform to solve some of the most pressing challenges in frontline operations. Companies use Tulip to error-proof processes with guided workflows, integrate industrial IoT (IIoT) technologies with legacy machines, and capture and analyze real-time operations data.

Get Agenda

BOOK NOW